Retour
Scinai Immunotherapeutics Ltd (SCNI) Gagner
Graphique du cours de l'action SCNI
SCNI Gagner
Scinai Immunotherapeutics Ltd
$0.67
-0.95%
$0
À la fermeture : Mar 24, 16:00:00 GMT-4
$0.67
0%
$0
Post-Marché: Mar 24, 18:43:50 GMT-4
Statistiques clés
Clôture préc.
$0.6801
Prix d'ouverture
$0.6716
Plage de la journée
$0.6716 - $0.6768
Plage de 52 semaines
$0.613 - $6.18
Volume
4.2K
Volume moyen
47.6K
Rendement en dividend
--
BPA (TTM)
0.00
Capitalisation boursière
$2.3M
Qu’est-ce que SCNI ?
Scinai Immunotherapeutics Ltd. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunomodulation therapies for infectious diseases. The Company’s core focus is to develop NanoAbs for the treatment of various diseases such as COVID-19, psoriasis, and asthma. The firm's product NanoAb is based on alpaca-derived nanosized antibodies (NanoAbs), also known as VHH-antibodies. Additionally, the Company offers manufacturing facilities, aseptic fill and finish suites, laboratories, and experienced professionals for other research and development companies. Scinai Immunotherapeutics Ltd operates in Israel.
Fonctionnalités
Ressources
© 2026 Finture Development Limited. Tous droits réservés.